After decades, FDA finally moves to pull ineffective decongestant off shelves
In a long-sought move, the Food and Drug Administration on Thursday formally began the process of abandoning oral doses of a ...
News Medical1d
Epigenetic silencing of BEND4 unveils new path for PDAC treatment
A novel discovery in the field of pancreatic cancer treatment has been unveiled, revealing the epigenetic silencing of BEND4 as a potential synthetic lethal marker for enhancing the efficacy of ATM ...
GlobalData on MSN1d
Penumbra reveals positive data for algorithm-assisted thrombectomy tech
Thrombectomy is a surgical procedure that typically uses a catheter to remove blood clots from vessels. Penumbra has ...
Penumbra’s CAVT technology shows benefits in pulmonary embolism
Penumbra (PEN) announced new data that demonstrate patients with intermediate-risk pulmonary embolism – PE – treated with ...
MassDevice2d
Penumbra has positive data for computer-assisted vacuum thrombectomy system
Penumbra (NYSE:PEN) today announced new data demonstrating improved outcomes with its computer-assisted vacuum thrombectomy ...
Cochrane2d
Does taking statins prevent blood clots from forming in the veins of people who have not previously had a blood clot?
Using statins for the primary prevention of VTE may slightly reduce the incidence of VTE and all-cause mortality. However, this effect is likely too weak to be considered significant. Statin use may ...
Endovascular Today4d
Resource Utilization and Outcomes With Penumbra’s CAVT in Intermediate-Risk PE Patients Compared to Other Treatment Modalities
A nationwide retrospective study evaluated health care resource utilization and outcomes among patients with ...
Endovascular Today5d
Endovascular Engineering’s Helo PE Thrombectomy System Evaluated in Pilot ENGULF Trial
Julie Bulman, MD, presented the results of the pilot ENGULF trial. The two-phase, prospective, single-arm study assessed the ...
MassDevice6d
The biggest cardiovascular tech stories from TCT 2024
The 2024 edition of Transcatheter Cardiovascular Therapeutics (TCT) once again highlighted significant innovations in ...
University of Pennsylvania gene therapy spinout Interius BioTherapeutics doses patient, achieves CAR therapy first
Its lead gene therapy candidate has the potential to be faster, less expensive, and more widely available than current CAR T ...